Singapore markets close in 47 minutes

BSGM Oct 2024 2.500 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.57000.0000 (0.00%)
As of 03:07PM EDT. Market open.
Full screen
Previous close1.5700
Open1.6000
Bid0.0000
Ask0.0000
Strike2.50
Expiry date2024-10-18
Day's range1.5700 - 1.6000
Contract rangeN/A
Volume2
Open interest2
  • GlobeNewswire

    BioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders

    Westport, CT, May 21, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or “Company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal visualization, has today issued the following Letter to Shareholders: Dear Shareholders, As the new CEO of BioSig, I am committed to keeping our shareholders updated to the best of my ability on the progress of our Company. Our new management team is firmly committed to both restoring

  • GlobeNewswire

    BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent

    Westport, CT, May 03, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) or (“BioSig” or "the Company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal visualization, today announced new appointments to its now fully constituted board of directors (the “Board”), which is comprised of a total of five (5) directors, three (3) of whom are classified as independent directors. The final compositions of the committees to the Board wi

  • GlobeNewswire

    BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately

    Mr. Amato will also serve on the Company’s Board of DirectorsWestport, CT, April 30, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) or (“BioSig” or "the Company"), a medical technology Company delivering unprecedented accuracy and precision to intra-cardiac signal visualization, today announced the appointment of Mr. Anthony Amato to the Position of Chief Executive Officer (“CEO”), effective immediately. Additionally, Mr. Amato will serve on the Company’s Board of Directors, w